FDA Drug Application (016847) for ISOPAQUE 440 by GE HEALTHCARE

Back to FDA Applications sponsored by GE HEALTHCARE

Application Number016847
Product Number001
FormINJECTABLE;INJECTION
Dosage0.78MG/ML;75.9MG/ML;0.15MG/ML;16.6MG/ML
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameISOPAQUE 440
Active IngredientCALCIUM METRIZOATE; MEGLUMINE METRIZOATE; METRIZOATE MAGNESIUM; METRIZOATE SODIUM



Back to FDA Applications sponsored by GE HEALTHCARE